Going against tradition

Article

When you attend an ophthalmology congress, what is it that you expect to gain? Does the opportunity to mingle with the elite inspire you to pay your congress fee, or do you want to learn new skills and improve your everyday practice? Certainly, people's motivations have been somewhat ambiguous in the past. With the style of the traditional meetings placing more emphasis on lecture-type presentations with no real discussion and less emphasis on the sharing of knowledge amongst participants, meeting attendees rarely had any input whatsoever.

Elsewhere, we focus on pharmaceutical therapies in ophthalmology. A bitter pill to swallow provides a good review of the medications most frequently used in an ophthalmologist's everyday practice and urges us to ask the question "Do we really know the side effects of the drugs we give our patients".

As always, please do keep your suggestions and article submissions coming in to Ophthalmology Times Europe.

Happy reading.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.